Display options
Share it on

Ther Adv Drug Saf. 2016 Jun;7(3):79-88. doi: 10.1177/2042098616641355. Epub 2016 Apr 01.

Factors associated with antidepressant use in residents with and without dementia in Australian aged care facilities.

Therapeutic advances in drug safety

Henna Hiltunen, Edwin C K Tan, Jenni Ilomäki, Sarah N Hilmer, Renuka Visvanathan, Tina Emery, Leonie Robson, Mary J Jones, Sirpa Hartikainen, J Simon Bell

Affiliations

  1. Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia.
  2. Kolling Institute of Medical Research, Sydney Medical School, Departments of Clinical Pharmacology and Aged Care, Royal North Shore Hospital, University of Sydney, Sydney, Australia.
  3. Adelaide Geriatrics Training and Research with Aged Care (GTRAC) Centre, School of Medicine, University of Adelaide, Adelaide, Australia.
  4. Resthaven Incorporated, Adelaide, Australia.
  5. Kuopio Research Centre of Geriatric Care, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
  6. Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, VIC 3052, Australia.

PMID: 27298718 PMCID: PMC4892406 DOI: 10.1177/2042098616641355

Abstract

OBJECTIVE: Depressive symptoms are highly prevalent in residential aged care facilities (RACFs). The prevalence of antidepressant use is increasing but the effectiveness of antidepressants in people with dementia is uncertain. The objective of the study was to investigate factors associated with antidepressant use in residents with and without dementia.

METHODS: This was a prospective cross-sectional study of 383 residents in six Australian RACFs. Data on health status, medications and demographics were collected by trained study nurses from April to August 2014. Logistic regression was used to compute adjusted odds ratios (AORs) and 95% confidence intervals (CIs) for factors associated with antidepressant use. Analyses were stratified by dementia and depression.

RESULTS: Overall, 183 (47.8%) residents used antidepressants. The prevalence of antidepressant use was similar among residents with and without dementia. Clinician-observed pain was inversely associated with antidepressant use in the main analysis (AOR = 0.56, 95% CI = 0.32-0.99) and in subanalyses for residents with documented depression (AOR = 0.51, 95% CI = 0.27-0.96). In residents with dementia, moderate quality of life was associated with a lower odds of antidepressant use compared with poor quality of life (AOR = 0.35, 95% C I= 0.13-0.95). In residents without dementia, analgesic use was associated with antidepressant use (AOR = 2.34, 95% CI = 1.07-5.18).

CONCLUSIONS: The prevalence of antidepressant use was similar in residents with and without dementia. Clinician-observed pain was inversely associated with antidepressant use but there was no association between self-reported pain and antidepressant use.

Keywords: antidepressants; dementia; depression; homes for the aged; pain

References

  1. Croat Med J. 2011 Feb;52(1):16-24 - PubMed
  2. Drugs Aging. 2015 Dec;32(12):1045-53 - PubMed
  3. Sleep. 1991 Dec;14(6):540-5 - PubMed
  4. J Pain. 2013 Apr;14(4):363-70 - PubMed
  5. J Am Med Dir Assoc. 2012 May;13(4):406.e13-8 - PubMed
  6. J Pain. 2009 Jun;10(6):619-27 - PubMed
  7. Health Technol Assess. 2013 Feb;17(7):1-166 - PubMed
  8. J Am Geriatr Soc. 2011 Aug;59(8):1412-20 - PubMed
  9. Drugs Aging. 2009;26(5):381-94 - PubMed
  10. Eur J Clin Pharmacol. 2015 Jul;71(7):897-9 - PubMed
  11. PLoS One. 2015 Feb 17;10(2):e0117926 - PubMed
  12. Am J Geriatr Pharmacother. 2009 Aug;7(4):210-9 - PubMed
  13. JAMA. 1963 Sep 21;185:914-9 - PubMed
  14. Drugs Aging. 2012 Sep;29(9):759-69 - PubMed
  15. Neurol Clin. 2013 May;31(2):377-403 - PubMed
  16. Psychosom Med. 2002 May-Jun;64(3):510-9 - PubMed
  17. Am J Geriatr Psychiatry. 2000 Winter;8(1):75-83 - PubMed
  18. BMJ Open. 2014 Jun 19;4(6):e005757 - PubMed
  19. Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):285-90 - PubMed
  20. Int J Geriatr Psychiatry. 2013 Mar;28(3):312-8 - PubMed
  21. Gerontologist. 2005 Oct;45 Spec No 1(1):27-36 - PubMed
  22. Am J Nurs. 2002 Feb;102(2):67-9 - PubMed
  23. Am J Geriatr Pharmacother. 2011 Apr;9(2):109-19 - PubMed
  24. Int Psychogeriatr. 2015 Apr;27(4):669-72 - PubMed
  25. Int Psychogeriatr. 2011 Nov;23(9):1520-5 - PubMed
  26. J Clin Epidemiol. 2010 Jul;63(7):721-7 - PubMed
  27. Int J Geriatr Psychiatry. 2013 May;28(5):441-9 - PubMed
  28. Stroke. 2012 Jan;43(1):32-7 - PubMed
  29. Ann Fam Med. 2013 May-Jun;11(3):245-50 - PubMed
  30. Geriatrics. 2004 Feb;59(2):47-51; quiz 52 - PubMed
  31. Int Psychogeriatr. 2010 Nov;22(7):1025-39 - PubMed
  32. Drugs Aging. 2005;22(9):793-800 - PubMed
  33. Int J Geriatr Psychiatry. 2001 Feb;16(2):139-46 - PubMed
  34. BMJ. 2011 Aug 02;343 :d4551 - PubMed
  35. J Am Geriatr Soc. 2007 Sep;55(9):1325-32 - PubMed
  36. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008191 - PubMed
  37. J Gerontol A Biol Sci Med Sci. 2009 Dec;64(12):1325-32 - PubMed
  38. J Am Med Dir Assoc. 2003 Jan-Feb;4(1):9-15 - PubMed
  39. J Am Geriatr Soc. 2011 Apr;59(4):577-85 - PubMed
  40. Curr Clin Pharmacol. 2015;10(3):194-203 - PubMed
  41. Consult Pharm. 2014 Apr;29(4):254-63 - PubMed

Publication Types